-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Endexx’s HYLA Division Secures Two Purchase Orders Exceeding 200,000 Units
Endexx’s HYLA Division Secures Two Purchase Orders Exceeding 200,000 Units
HYLA Completes First Production Run on New 4500 Puff Vape System
CAVE CREEK, AZ, Sept. 27, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Endexx Corporation (OTC:EDXC), a provider of innovative, plant-based, and sustainable health and skincare products, today announces that its recently acquired (controlling-interest) HYLA division, secured two major purchase orders for its new innovative vape-delivery product that holds 4500 puffs per built in cartridge unit.
Combined, the orders represent a 150,000-unit order and a 52,000-unit order for over 200,000 units within the first month of the acquisition of Hyla. The newly innovated "No-Nic" (zero- nicotine) vape product produced by HYLA offers 4500 puffs per disposable unit. This expanded puff capacity far exceeds the capacity of its competitor's products worldwide. Formulated with Guarana and Levodopa, this product is forecasted to replace the recently banned nicotine products sold internationally where vape products are available.
Todd Davis, CEO of Endexx, stated "HYLA's new product line fills a major gap created by the banning of flavored nicotine vape products. We believe plant-derived products are the alternative and the solution that meets market demands today. The two purchase orders came from prominent distributors in the West Coast region of the US and a large western region in Asia. These orders expand both our international and domestic distribution networks helping to expedite our growth initiatives."
About Hyla
Hyla develops and distributes zero-nicotine plant-powered, vape-delivered products made with vegan formulations and functional plant extract ingredients. Hyla harnesses the power of Guarana and Levodopa to create plant-derived high-performance botanical products. For more information:
About Endexx Corporation
Endexx Corporation develops and distributes all natural, plant-derived topical skincare products. Its products vary from balms, creams, lotions, butters, masks, scrubs, and oils, all with the shared purpose of healthy skin and grooming wellness. The science behind these products involves a decade of clinical research in the field and lab work to provide functional formulation with ingredients for optimal absorption and support of skin health.
Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995
We caution that any forward-looking statements (as such term is defined in the U.S. Private Securities Litigation Reform Act of 1995) contained in this press release or made by us, our management, or our spokespeople involve risks and uncertainties and are subject to change based on various factors, many of which are beyond our control. Accordingly, our future performance and financial results may differ materially from those expressed or implied in any such forward-looking statements. Forward-looking statements include, without limitation, statements regarding our future operating results, the implementation and impact of our strategic plans, and our ability to meet environmental, social, and governance goals. Words such as "estimate," "commit," "target," "goal," "project," "plan," "believe," "seek," "strive," "expect," "anticipate," "intend," "potential" and any similar expressions may identify forward-looking statements. Risks associated with the following factors, among others, could affect our financial performance and cause actual results to differ materially from those expressed or implied in any forward-looking statements:
Except as may be required by law, we assume no obligation and do not intend to make publicly available any update or other revisions to any of the forward-looking statements contained in this press release to reflect circumstances existing after the date of this press release or to reflect the occurrence of future events, even if experience or future events make it clear that any expected results expressed or implied by those forward-looking statements will not be realized. More information on potential factors that could affect our results is included "Risk Factors" in our Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 31, 2022.
For further information, please contact:
Endexx Corporation
Endexx@endexx.com
480-595-6900
Investors:
Scott Arnold
CORE IR
scotta@coreir.com
Media:
Jules Abraham
CORE IR
julesa@coreir.com
917-885-7378
HYLA Completes First Production Run on New 4500 Puff Vape System
Hyla在新的4500泡芙Vape系統上完成首次生產
CAVE CREEK, AZ, Sept. 27, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Endexx Corporation (OTC:EDXC), a provider of innovative, plant-based, and sustainable health and skincare products, today announces that its recently acquired (controlling-interest) HYLA division, secured two major purchase orders for its new innovative vape-delivery product that holds 4500 puffs per built in cartridge unit.
亞利桑那州洞穴克里克,9月2022年2月27日(Global Newswire)--Via NewMediaWire-Endexx Corporation(場外交易代碼:EDXC)是一家創新、植物性和可持續的健康和護膚產品供應商,該公司今天宣佈,其最近收購的(控股權)Hyla部門獲得了其新的創新電子煙輸送產品的兩個主要訂單,該產品每個內置墨盒單元可容納4500口煙。
Combined, the orders represent a 150,000-unit order and a 52,000-unit order for over 200,000 units within the first month of the acquisition of Hyla. The newly innovated "No-Nic" (zero- nicotine) vape product produced by HYLA offers 4500 puffs per disposable unit. This expanded puff capacity far exceeds the capacity of its competitor's products worldwide. Formulated with Guarana and Levodopa, this product is forecasted to replace the recently banned nicotine products sold internationally where vape products are available.
這些訂單加在一起,代表着在收購Hyla的第一個月內訂購150,000個單位和52,000個單位,訂購超過200,000個單位。由Hyla生產的最新創新的“無煙”(零尼古丁)電子煙產品,每一次性單位可提供4500支煙。這種擴大的吞吐能力遠遠超過了其競爭對手產品在全球的產能。這種產品由瓜拉那和左旋多巴配製而成,預計將取代最近在國際上銷售的被禁止的尼古丁產品,那裏有VAPE產品可用。
Todd Davis, CEO of Endexx, stated "HYLA's new product line fills a major gap created by the banning of flavored nicotine vape products. We believe plant-derived products are the alternative and the solution that meets market demands today. The two purchase orders came from prominent distributors in the West Coast region of the US and a large western region in Asia. These orders expand both our international and domestic distribution networks helping to expedite our growth initiatives."
Endexx首席執行官託德·戴維斯表示:“Hyla的新產品線填補了禁止加味尼古丁電子煙產品帶來的一個重大空白。我們相信植物衍生產品是滿足當今市場需求的替代產品和解決方案。這兩個採購訂單來自美國西海岸地區和亞洲西部地區的知名分銷商。這些訂單擴大了我們的國際和國內分銷網絡,有助於加快我們的增長計劃。”
About Hyla
關於希拉
Hyla develops and distributes zero-nicotine plant-powered, vape-delivered products made with vegan formulations and functional plant extract ingredients. Hyla harnesses the power of Guarana and Levodopa to create plant-derived high-performance botanical products. For more information:
Hyla開發和分銷由素食配方和功能性植物提取物成分製成的零尼古丁植物動力、蒸氣輸送產品。Hyla利用Guarana和Levodopa的力量創造出植物衍生的高性能植物產品。有關詳細信息,請參閲:
About Endexx Corporation
關於Endexx公司
Endexx Corporation develops and distributes all natural, plant-derived topical skincare products. Its products vary from balms, creams, lotions, butters, masks, scrubs, and oils, all with the shared purpose of healthy skin and grooming wellness. The science behind these products involves a decade of clinical research in the field and lab work to provide functional formulation with ingredients for optimal absorption and support of skin health.
Endexx公司開發和分銷所有天然、植物衍生的局部護膚品。它的產品種類繁多,從香膏、面霜、乳液、黃油、面膜、磨砂膏和油,所有這些都以健康皮膚和美容健康為共同目標。這些產品背後的科學包括十年的現場臨牀研究和實驗室工作,以提供含有最佳吸收和支持皮膚健康的成分的功能配方。
Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995
《1995年私人證券訴訟改革法》下的安全港聲明
We caution that any forward-looking statements (as such term is defined in the U.S. Private Securities Litigation Reform Act of 1995) contained in this press release or made by us, our management, or our spokespeople involve risks and uncertainties and are subject to change based on various factors, many of which are beyond our control. Accordingly, our future performance and financial results may differ materially from those expressed or implied in any such forward-looking statements. Forward-looking statements include, without limitation, statements regarding our future operating results, the implementation and impact of our strategic plans, and our ability to meet environmental, social, and governance goals. Words such as "estimate," "commit," "target," "goal," "project," "plan," "believe," "seek," "strive," "expect," "anticipate," "intend," "potential" and any similar expressions may identify forward-looking statements. Risks associated with the following factors, among others, could affect our financial performance and cause actual results to differ materially from those expressed or implied in any forward-looking statements:
我們提醒,本新聞稿中包含的或由我們、我們的管理層或我們的發言人做出的任何前瞻性聲明(根據1995年美國私人證券訴訟改革法中的定義)都涉及風險和不確定因素,並可能因各種因素而發生變化,其中許多因素是我們無法控制的。因此,我們未來的業績和財務結果可能與任何此類前瞻性陳述中明示或暗示的情況大不相同。前瞻性陳述包括但不限於關於我們未來的經營結果、我們戰略計劃的實施和影響以及我們實現環境、社會和治理目標的能力的陳述。諸如“估計”、“承諾”、“目標”、“目標”、“項目”、“計劃”、“相信”、“尋求”、“努力”、“期望”、“預期”、“打算”、“潛在”等詞彙以及任何類似的表述都可能識別前瞻性表述。與以下因素相關的風險可能會影響我們的財務業績,並導致實際結果與任何前瞻性陳述中明示或暗示的結果大不相同:
Except as may be required by law, we assume no obligation and do not intend to make publicly available any update or other revisions to any of the forward-looking statements contained in this press release to reflect circumstances existing after the date of this press release or to reflect the occurrence of future events, even if experience or future events make it clear that any expected results expressed or implied by those forward-looking statements will not be realized. More information on potential factors that could affect our results is included "Risk Factors" in our Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 31, 2022.
除非法律另有要求,否則我們沒有義務也不打算公開提供對本新聞稿中包含的任何前瞻性陳述的任何更新或其他修訂,以反映本新聞稿發佈之日後存在的情況或未來事件的發生,即使經驗或未來事件明確表明,這些前瞻性陳述中明示或暗示的任何預期結果將無法實現。有關可能影響我們業績的潛在因素的更多信息,請參閲我們於2022年3月31日提交給美國證券交易委員會的Form 10-K年度報告中的“風險因素”。
For further information, please contact:
如需更多信息,請聯繫:
Endexx Corporation
Endexx@endexx.com
480-595-6900
Endexx公司
郵箱:endexx@endexx.com
480-595-6900
Investors:
Scott Arnold
CORE IR
scotta@coreir.com
投資者:
斯科特·阿諾德
核心紅外光譜
郵箱:Scotta@coreir.com
Media:
Jules Abraham
CORE IR
julesa@coreir.com
917-885-7378
媒體:
朱爾斯·亞伯拉罕
核心紅外光譜
郵箱:julesa@coreir.com
917-885-7378
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧